{"id":235,"date":"2023-06-09T15:17:04","date_gmt":"2023-06-09T06:17:04","guid":{"rendered":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/?page_id=235"},"modified":"2024-04-03T16:08:50","modified_gmt":"2024-04-03T07:08:50","slug":"y2006","status":"publish","type":"page","link":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/en\/publication\/y2006\/","title":{"rendered":"2006"},"content":{"rendered":"<h2>2006<\/h2>\r\n<ol>\r\n    <li>X.Y. Gao, K. Nishimura, F. Hirayama, H. Arima, K. Uekama, G. Schmid, K. Terao, D. Nakata, H. Fukumi,<br>\r\n        Enhanced Dissolution and Bioavailability of Coenzyme Q<sub>10<\/sub> in Dogs Obtained by Inclusion Complexation with \u03b3-Cyclodextrin,<br>\r\n        <i>Asian J. Pharm. Sci.<\/i>, <strong>1<\/strong> (2), 95-102 (2006).<\/li>\r\n    <li>K. Anzai, H. Kono, J.I. Mizoguchi, T. Yanagi, F. Hirayama, H. Arima, K. Uekama,<br>\r\n        Two-dimensional <sup>13<\/sup>C-<sup>1<\/sup>H Heteronuclear Correlation NMR Spectroscopic Studies for the Inclusion Complex of Cyclomaltoheptaose (\u03b2-Cyclodextrin) with a New Helicobacter Pylori Eradicating Agent (TG44) in the Amorphous State,<br>\r\n        <i>Carbohydr. Res.<\/i>, <strong>341<\/strong> (4), 499-506 (2006).<\/li>\r\n    <li>Y. Sonoda, F. Hirayama, H. Arima, Y. Yamaguchi, W. Saenger, K. Uekama,<br>\r\n        Cyclodextrin-based Isolation of Ostwald\u2019s Metastable Polymorphs Occurring during Crystallization,<br>\r\n        <i>Chem. Commun.<\/i>, <strong>2006 (5)<\/strong>, 517-519 (2006). <strong>Selected as a hot article.<\/strong><\/li>\r\n    <li>Y. Hagiwara, H. Arima, Y. Miyamoto, F. Hirayama, K. Uekama,<br>\r\n        Preparation and Pharmaceutical Evaluation of Liposomes Entrapping Salicylic Acid\/\u03b3-Cyclodextrin Conjugate, <br>\r\n        <i>Chem. Pharm. Bull.<\/i>, <strong>54<\/strong> (1), 26-32 (2006).<\/li>\r\n    <li>T. Hara, F. Hirayama, H. Arima, Y. Yamaguchi, K. Uekama,<br>\r\n        Improvement of Solubility and Oral Bioavailability of 2-(N-Cyanoimino)-5-{(E)-4- styrylbenzylidene}-4-oxothiazolidine (FPFS-410) with Antidiabetic and Lipid-lowering Activities in Dogs by 2-Hydroxypropyl-\u03b2-cyclodextrin,<br>\r\n        <i>Chem. Pharm. Bull.<\/i>, <strong>54<\/strong> (3), 344-349 (2006). <strong>Selected as a journal cover of issue 3.<\/strong><\/li>\r\n    <li>T. Hara, H. Arima, F. Hirayama, K. Uekama,<br>\r\n        Enhanced Bioavailability of a New Thiazolidine Derivative FPFS-410, an Antidiabetic and Lipid-lowering Drug, after Oral Administration of Its Hydroxypropyl-\u03b2-cyclodextrin Complex to Bile Duct-cannulated Rats,<br>\r\n        <i>J. Pharm. Sci.<\/i>, <strong>95<\/strong>, 1771-1782 (2006).<\/li>\r\n    <li>Y. Sonoda, F. Hirayama, H. Arima, Y. Yamaguchi, W. Saenger, K. Uekama,<br>\r\n        Selective Crystallization of the Metastable Form IV Polymorph of Tolbutamide in the Presence of 2,6-Di-<i>O<\/i>-methyl-\u03b2-cyclodextrin in Aqueous Solution,<br>\r\n        <i>Crystal Growth \uff06 Design<\/i>, <strong>6<\/strong> (5), 1181-1185 (2006).<\/li>\r\n    <li>K. Motoyama, H. Arima, H. Toyodome, T. Irie, F. Hirayama, K. Uekama,<br>\r\n        Effect of 2,6-Di-<i>O<\/i>-methyl-\u03b1-cyclodextrin on Hemolysis and Morphological Changes in Rabbit\u2019s Red Blood Cells,<br>\r\n        <i>Eur. J. Pharm. Sci.<\/i>,<strong>29<\/strong> , 111-119 (2006),<\/li>\r\n    <li>H. Arima, Y. Chihara, M. Arizono, S. Yamashita, K. Wada, F. Hirayama, K. Uekama,<br>\r\n        Enhancement of Gene Transfer Activity Mediated by Mannosylated Dendrimer\/\u03b1-Cyclodextrin Conjugate (Generation 3, G3),<br>\r\n        <i>J. Control. Release<\/i>, <strong>116<\/strong> (1), 64-74 (2006).<\/li>\r\n    <li>H. Arima, Y. Hagiwara, F. Hirayama, K. Uekama,<br>\r\n        Enhancement of Antitumor Effect of Doxorubcin by Its Complexation with \u03b3-Cyclodextrin in Pegylated Liposomes,<br>\r\n        <i>J. Drug Targeting<\/i>, <strong>14<\/strong> (4), 225-232 (2006).<\/li>\r\n    <li>Y. Hagiwara, H. Arima, F. Hirayama, K. Uekama,<br>\r\n        Prolonged Retention of Doxorubicin in Tumor Cells by Encapsulation of \u03b3-Cyclodextrin Complex in Pegylated Liposomes,<br>\r\n        <i>J. Incl. Phenom. Macrocycl. Chem.<\/i>, <strong>56<\/strong> (1-2), 65-68 (2006).<\/li>\r\n    <li>K. Motoyama, H. Arima, F. Hirayama, K. Uekama,<br>\r\n        Inhibitory Effects of 2,6-Di-O-methyl-3-O-acetyl-\u03b2-cyclodextrins with Various Degrees of Substitution of Acetyl Group on Macrophage Activation and Endotoxin Shock Induced by Lipopolysaccharide,<br>\r\n        <i>J. Incl. Phenom. Macrocycl. Chem.<\/i>, <strong>56<\/strong> (1-2), 75-79 (2006).<\/li>\r\n    <li>T. Tsutsumi, H. Arima, F. Hirayama, K. Uekama,<br>\r\n        Potential Use of Dendrimer\/\u03b1-Cyclodextrin Conjugate as a Novel Carrier for Small Interfering RNA (siRNA),<br>\r\n        <i>J. Incl. Phenom. Macrocycl. Chem.<\/i> , <strong>56<\/strong> (1-2), 81-84 (2006).<\/li>\r\n    <li>K. Nishimura, R. Hidaka, F. Hirayama, H. Arima, K. Uekama,<br>\r\n        Improvement of Dispersion and Release Properties of Nifedipine in Suppositories by Complexation with 2-Hydroxypropyl-\u03b2-cyclodextrin,<br>\r\n        <i>J. Incl. Phenom. Macrocycl. Chem.<\/i>, <strong>56<\/strong> (1-2), 85-88 (2006).<\/li>\r\n    <li>Y. Chihara, H. Arima, M. Arizono, K. Wada, F. Hirayama, K. Uekama,<br>\r\n        Serum-resistant Gene Transfer Activity of Mannosylated Dendrimer\/\u03b1-Cyclodextrin Conjugate (G3),<br>\r\n        <i>J. Incl. Phenom. Macrocycl. Chem.<\/i>, <strong>56<\/strong> (1-2), 89-93 (2006).<\/li>\r\n    <li>T. Hara, F. Hirayama, H. Arima, Y. Yamaguchi, K. Uekama,<br>\r\n        Prominent Solubilizing Effect of 2-Hydoxypropyl-\u03b2-cyclodextrin on a New Thiazolidine Derivative (FPFS-410) with Antidiabetic and Lipid-lowering Activities through Inclusion Complex Formation,<br>\r\n        <i>J. Incl. Phenom. Macrocycl. Chem.<\/i>, <strong>56<\/strong> (1-2), 135-139 (2006).<\/li>\r\n    <li>T. Hara, H. Arima, F. Hirayama, K. Uekama,<br>\r\n        Enhanced Bioavailability of a New Thiazolidine Derivative FPFS-410, an Antidiabetic and Lipid-lowering Drug, after Oral Administration of Its Hydroxypropyl-\u03b2-cyclodextrin Complex to Bile Duct-cannulated Rats,<br>\r\n        <i>J. Pharm. Sci.<\/i>, <strong>95<\/strong> (8), 1771-1782 (2006).<\/li>\r\n    <li>S. Tavornvipas, F. Hirayama, S. Takeda, H. Arima, K. Uekama,<br>\r\n        Effects of Cyclodextrins on Chemically- and Thermally-induced Unfolding and Aggregation of Lysozyme and Basic Fibroblast Growth Factor,<br>\r\n        <i>J. Pharm. Sci.<\/i>, <strong>95<\/strong> (12), 2722-2729 (2006). <\/li>\r\n    <li>K. Terao, D. Nakata, H. Fukumi, G. Schmid, H. Arima, F. Hirayama, K. Uekama,<br>\r\n        Enhancement of Oral Bioavailability of Coenzyme Q<sub>10<\/sub> by the Complexation with \u03b3-Cyclodextrin in Healthy Adult Volunteers,<br>\r\n        <i>Nutr. Res.<\/i>, <strong>26<\/strong> (10), 503-508 (2006).<\/li>\r\n    <li>K. Uekama, F. Hirayama, H. Arima,<br>\r\n        Recent Aspects of Cyclodextrin-based Drug Delivery System,<br>\r\n        <i>J. Incl. Phenom. Macrocycl. Chem.<\/i>, <strong>56<\/strong> (1-2), 3-8 (2006). <\/li>\r\n    <li>K. Uekama, F. Hirayama, H. Arima,<br>\r\n        Pharmaceutical applications of cyclodextrins and their derivatives, &#8220;Cyclodextrins and their complexes&#8221;, Ed. by H. Dodziuk, Wiley-VCH Verlag, Weinheim, 2006, pp. 381-422.<\/li>\r\n    <li>\u5e73\u5c71\u6587\u4fca,<br>\r\n        \u201c\u7b2c 9 \u7ae0\u3000\u30bf\u30fc\u30b2\u30c6\u30a3\u30f3\u30b0\u201d, \u201c\u85ac\u5b66\u6559\u79d1\u66f8\u30b7\u30ea\u30fc\u30ba\u7b2c 7 \u5dfb\u3000\u88fd\u5264\u5316\u306e\u30b5\u30a4\u30a8\u30f3\u30b9\u201d, \u6771\u4eac\u5316\u5b66\u540c\u4eba, \u6771\u4eac, 2006, pp.169-177.<\/li>\r\n<\/ol>","protected":false},"excerpt":{"rendered":"2006 X.Y. Gao, K. Nishimura, F. Hirayama, H. Arima, K. Uekama, G. Schmid, K. Terao, D. Nakata, H. Fukumi, Enha&#8230; <a class=\"view-article\" href=\"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/en\/publication\/y2006\/\">View Article<\/a>","protected":false},"author":1,"featured_media":0,"parent":22,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page_en.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-235","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/wp-json\/wp\/v2\/pages\/235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/wp-json\/wp\/v2\/comments?post=235"}],"version-history":[{"count":4,"href":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/wp-json\/wp\/v2\/pages\/235\/revisions"}],"predecessor-version":[{"id":539,"href":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/wp-json\/wp\/v2\/pages\/235\/revisions\/539"}],"up":[{"embeddable":true,"href":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/wp-json\/wp\/v2\/pages\/22"}],"wp:attachment":[{"href":"https:\/\/www.ph.sojo-u.ac.jp\/~dio\/wp-json\/wp\/v2\/media?parent=235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}